J. F. Seitz - Concepedia

Author

J. F. Seitz

Also Known As

Allison J. Seitz, Anja Waidner, J F Seitz, J Seitz, J. -F. Seitz, J. F. Seitz, J. Seitz, J.-F. Seitz, J.F. Seitz, Jean-Francois Seitz

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Institut Paoli-Calmettes Inserm Assistance Publique – Hôpitaux de Paris Hôpital de la Timone Centre Antoine Lacassagne

About

J. F. Seitz is an author at Institut Paoli-Calmettes specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	988
2	Health Sciences	5	5	355
3	Pathology	4	4	214
4	Gastroenterology	2	2	142
5	Immunology	1	1	45

J. F. Seitz

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer Daniel J. Sargent, Silvia Marsoni, Geneviève Monges, Journal of Clinical Oncology	2010	1.6K
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study Julien Edeline, M. Benabdelghani, Aurélie Bertaut, Journal of Clinical Oncology	2019	504
Fine-Needle Aspiration Cytology Guided by Endoscopic Ultrasonography: Results in 141 Patients Marc Giovannini, J. F. Seitz, G. Monges, Endoscopy	1995	450
Survival Following Recurrence in Stage II and III Colon Cancer: Findings From the ACCENT Data Set Michael J. O’Connell, Megan E. Campbell, Richard M. Goldberg, Journal of Clinical Oncology	2008	216
Final results of a randomised trial comparing ‘Tomudex’® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer David Cunningham, John Zalcberg, U. Räth, Annals of Oncology OncologyGastrointestinal OncologyMedicineRandomised TrialColorectal Cancer	1996	204
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials Romain Cohen, Jack Fiskum, Greg Yothers, Journal of Clinical Oncology	2020	167
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab Anthony Dohan, B. Gallix, Boris Guiu, Gut	2019	135
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer Franck Bonnetain, Olivier Bouché, Pierre Michel, Annals of Oncology Surgical OncologySpitzer QualityEsophageal CancerComparative Longitudinal QualityMedicine	2006	119
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients Michel Ducreux, Emmanuel Mitry, Mahmoud Ould-Kaci, Annals of Oncology Pancreatic CancerGastrointestinal OncologyMedicinePhase Ii StudyMolecular Oncology	2004	114
Ultrasound-guided percutaneous alcohol injection of small liver metastases. Results in 40 patients Marc Giovannini, J. F. Seitz Cancer	1994	96

Page 1